Attached files
file | filename |
---|---|
EX-23.1 - EX-23.1 - Rain Therapeutics Inc. | d26404dex231.htm |
EX-10.13 - EX-10.13 - Rain Therapeutics Inc. | d26404dex1013.htm |
EX-10.4 - EX-10.4 - Rain Therapeutics Inc. | d26404dex104.htm |
EX-10.3 - EX-10.3 - Rain Therapeutics Inc. | d26404dex103.htm |
EX-3.1 - EX-3.1 - Rain Therapeutics Inc. | d26404dex31.htm |
S-1/A - S-1/A - Rain Therapeutics Inc. | d26404ds1a.htm |
Exhibit 5.1
Client: 80586-00002 |
April 19, 2021
Rain Therapeutics Inc.
8000 Jarvis Avenue, Suite 204
Newark, CA 94560
Re: | Rain Therapeutics Inc. |
Registration Statement on Form S-1 (File No. 333-254998) |
Ladies and Gentlemen:
We have examined the Registration Statement on Form S-1, File No. 333-254998, as amended (the Registration Statement), of Rain Therapeutics Inc., a Delaware corporation (the Company), filed with the Securities and Exchange Commission (the Commission) pursuant to the Securities Act of 1933, as amended (the Securities Act), in connection with the offering by the Company of up to 8,455,882 shares of the Companys common stock, par value $0.001 per share (the Shares).
In arriving at the opinion expressed below, we have examined originals, or copies certified or otherwise identified to our satisfaction as being true and complete copies of the originals, of specimen Common Stock certificates and such other documents, corporate records, certificates of officers of the Company and of public officials and other instruments as we have deemed necessary or advisable to enable us to render the opinions set forth below. In our examination, we have assumed without independent investigation the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies.
Based upon the foregoing, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that the Shares, when issued against payment therefor as set forth in the Registration Statement, will be validly issued, fully paid and non-assessable.
We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption Legal Matters in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission.
April 19, 2021
Page 2
Very truly yours,
/s/ Gibson, Dunn & Crutcher LLP